Back to Search Start Over

Supplemental Figure 2 from Herbacetin Is a Novel Allosteric Inhibitor of Ornithine Decarboxylase with Antitumor Activity

Authors :
Zigang Dong
Ann M. Bode
Young Il Yeom
Kanamata Reddy
Sung-Hyun Kim
Sung-Young Lee
Ji Won Jung
Hee Eun Kang
Souren Paul
Sun Chul Kang
Jong-Eun Kim
Eun Jin Cho
Hanyong Chen
Jung-Hyun Shim
Angelo Pugliese
Yong-Yeon Cho
Myoung Ok Kim
Do Young Lim
Naomi Oi
Mee-Hyun Lee
Eunmiri Roh
Dong Joon Kim
Publication Year :
2023
Publisher :
American Association for Cancer Research (AACR), 2023.

Abstract

Effect of herbacetin on activity of various kinases. Herbacetin has no effect on (A) CHK1, (B) EGFR, (C) GSK3beta, (D) JNK1, (E) JNK2, (F) ERK1, (G) ERK2, (H) MEK1, (I) AKT1, (J) AKT2, (K) RSK2, (L) p38 or (M) PI3-K kinase activity or on (N) AdoMetDC activity. The effect of herbacetin on kinase or enzyme activity was determined by using an in vitro kinase or enzyme assay. All data are represented as mean values {plus minus} S.D. of values from duplicates experiments.

Details

Database :
OpenAIRE
Accession number :
edsair.doi.dedup.....80a518ed82eb9ff55965a9a35f45d90b